Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens

Michael S. Khodadoust1, Niclas Olsson2, Lisa E. Wagar3, Ole A. W. Haabeth1, Binbin Chen1,4, Kavya Swaminathan2, Keith Rawson2, Chih Long Liu1, David Steiner5, Peder Lund3, Samhita Rao2, Lichao Zhang2, Caleb Marceau3, Henning Stehr1, Aaron M. Newman1,6, Debra K. Czerwinski1, Victoria E. H. Carlton7, Martin Moorhead7, Malek Faham7, Holbrook E. Kohrt1, Jan Carette3, Michael R. Green1, Mark M. Davis3,8, Ronald Levy1, Joshua E. Elias2 & Ash A. Alizadeh1,6,9 1Department of Medicine, Division of Oncology, Stanford University, Stanford, California 94305, USA. 2Department of Chemical & Systems Biology, Stanford University, Stanford, California 94305, USA. 3Department of Microbiology & Immunology, Stanford University, Stanford, California 94305, USA. 4Department of Genetics, Stanford University, Stanford, California 94305, USA. 5Department of Pathology, Stanford University, Stanford, California 94305, USA. 6Center for Cancer Systems Biology, Stanford University, Stanford, California 94305, USA. 7Adaptive Biotechnologies, South San Francisco, California 94080, USA. 8Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA. 9Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, California 94305, USA.